HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats.

AbstractBACKGROUND:
Galacto-oligosaccharides potentially attenuate colonic inflammation by two mechanisms: through beneficial effects on intestinal microflora and by increasing the colonic short-chain fatty acid concentration. The purpose of this study was to investigate the effects of galacto-oligosaccharides on the development of inflammation and on the growth of bifidobacteria in trinitrobenzene sulphonic acid (TNBS)-induced colitis, a model that has been shown to benefit from short-chain fatty acid administration and to be associated with alterations in the colonic microflora.
METHODS:
Rats were given daily either whey-derived or lactose-derived galacto-oligosaccharides (4 g kg(-1) day(-1), p.o.); starting 10 days before colitis induction, or dexamethasone (2 mg kg(-1) day(-1), s.c., a positive control), starting at colitis induction. Colon wet weight, macroscopic damage and myeloperoxidase activity were assessed 72 h after the induction of colitis. Faecal bifidobacteria were counted at the beginning of the study, and immediately before and 72 h after colitis induction.
RESULTS:
Galacto-oligosaccharides increased the colonic levels of bifidobacteria but also the levels of other bacterial species. Neither whey-derived nor lactose-derived galacto-oligosaccharides reduced the severity of inflammation.
CONCLUSIONS:
Galacto-oligosaccharides are able to modify gut microflora in severe TNBS-induced colitis, but unable to attenuate the inflammation.
AuthorsR Holma, P Juvonen, M Z Asmawi, H Vapaatalo, R Korpela
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 37 Issue 9 Pg. 1042-7 (Sep 2002) ISSN: 0036-5521 [Print] England
PMID12374229 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Galactans
  • Glucocorticoids
  • Oligosaccharides
  • Dexamethasone
  • Trinitrobenzenesulfonic Acid
Topics
  • Animals
  • Bifidobacterium (physiology)
  • Body Weight
  • Colitis (chemically induced, microbiology, prevention & control)
  • Colon (drug effects, microbiology)
  • Colony Count, Microbial
  • Dexamethasone (administration & dosage)
  • Galactans (administration & dosage)
  • Glucocorticoids (administration & dosage)
  • Intestinal Mucosa (drug effects, microbiology)
  • Male
  • Models, Animal
  • Oligosaccharides (administration & dosage)
  • Rats
  • Trinitrobenzenesulfonic Acid (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: